Innovations in Neuro-Oncology for the Advanced Practice Provider 2024 — On Demand


Innovations in Neuro-Oncology for the Advanced Practice Provider 2024 — On Demand Banner



Date & Location
Wednesday, October 30, 2024, 8:20 AM - Thursday, October 30, 2025, 11:00 PM

Specialties
Specialties - Geriatric Medicine, Hospice and Palliative Medicine, Immigrant Health and Cancer Disparities, Neurology, Neuro-Oncology, Neuropathology, Neuroradiology, Neurosurgery, Nurse Practitioner, Nursing, Spine Surgery

Overview

Neuro-oncology is a uniquely specialized field requiring providers to have advanced knowledge and understanding to optimize patient care. This course, originally held live on September 18, 2024, is designed to update Advanced Practice Providers and other healthcare professionals on the latest treatments and clinical trials, enhancing their understanding of the complex management of patients living with cancers of the central nervous system (CNS). The program covers topics such as neurosurgical innovations, novel therapies, the challenges and successes of clinical trials, and the commitment to increasing access to available treatments for all individuals with CNS cancers. See below for a list of presentations available in this on-demand offering. For further information about this program, view the brochure from the live course.

  • Keynote Address: Increasing Access to Care and Health Equity in Neuro-Oncology
  •  Introduction to Clinical Trials
    • The Selection Process for Clinical Trial
    • The Phases of Clinical Trial
  • Disrupting Tumor Viability
    • INDIGOing, Going, Gone
    • Turning Up the Heat with LITT Surgery
  • Novel Treatments in Neuro-Oncology
    • Fundamentals of Immunotherapy
    • Fundamentals of Targeted Therapy
  • Crossing the Blood Brain Barrier
    • Multimodality Management for Brain Metastasis
    • Intrathecal Therapies in Treating Leptomeningeal Disease
    • Protons and Photons
  • Neurological Complications of Cancer
    • An Autonomic Storm is Coming
    • Neurotoxicity in CAR-T Cell Therapy
  • Looking Ahead to the Future
    • The Possibilities of CAR-T Cell Treatment in Brain Cancer
    • Endoscopy and Robotics in Spine Oncology

Objectives
At the conclusion of this program, attendees will be able to:

  1. Engage participants in a comprehensive learning experience through a case study approach.
  2. Explore the advances in novel therapies and clinical trials for cancers of the central nervous system.
  3. Discuss the challenges and successes of clinical trial in neuro-oncology.
  4. Highlight innovations in neurosurgical procedures and early recovery after surgery.
  5. Employ early recognition and treatment of neuro-oncologic emergencies.

Registration

Access to the course content requires registration. Once registered, all materials, including relevant financial disclosures and instructions for claiming credit, are located under the 'Course Content' tab. This on-demand program is available for purchase until October 30, 2025. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through December 31, 2025. To enroll, please click the 'Register' tab at the top of the page.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

On Demand Access Fees

Physicians (MDs, PhDs, and DOs): $249
Advanced Practice Providers: $199
Nurses and Other Healthcare Professionals: $149
Residents, Fellows, and APP Students $25
MSK Employees: Complimentary

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

MOC/CC points earned will be reported to the board within 45 days of completing the post-course evaluation.

Advanced Practice Providers

  • American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
  • American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
  • National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME.


Recorded/Review Date: September 18, 2024 | Original Release Date: October 30, 2024 | Termination Date: December 31, 2025